N-Acetylgalactosaminyltransferases

Download PDF

Recent Publications on N-Acetylgalactosaminyltransferases:
Useful markers for detecting minimal residual disease in cases of neuroblastoma. Neuroblastoma (NB), which is a malignant tumor of young children derived...	1st July, 2008	Research Unit of Clinical Medicine, College of Pharmacy, Nihon University,	Biol Pharm Bull. 2008 Jun;31(6):1071-4.
The catalytic and lectin domains of UDP- GalNAc :Polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection. UDP-GalNAc: Polypeptide alpha-N-Acetylgalactosaminyltransferases...	20th June, 2008	NIDDK, National Institutes of Health, Bethesda, MD 20892.	J Biol Chem. 2008 Jun 18;. DOI Direct Link
A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome. OBJECTIVE: Hyperostosis-hyperphosphataemia syndrome (HHS) is a rare...	17th June, 2008	Department of Medical Sciences, Uppsala University Hospital, Ing.70, 3 tr,	Eur J Endocrinol. 2008 Jun;158(6):929-34. Epub 2008 Mar 5. DOI Direct Link
[Structural and functional biology for post translational modification and transport in eukaryotes] The TGF-beta superfamily of secreted signalling molecules plays a pivotal...	31st May, 2008		Tanpakushitsu Kakusan Koso. 2008 Apr;53(5):628-31.
ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes. The final step in the enzymatic synthesis of the ABO(H) blood group A and...	29th May, 2008	Department of Biochemistry and Microbiology, University of Victoria,	J Biol Chem. 2008 Apr 11;283(15):10097-108. Epub 2008 Jan 11. DOI Direct Link
→View more research publications.

BioNews Results for N-Acetylgalactosaminyltransferases:
The Board of Trustees of H&Q Healthcare Investors Adopts Amendments to the By-laws of the Fund	Pharma Live:  Jul 18 2008 2:45PM Matching: n
The Board of Trustees of H&Q Healthcare Investors Adopts Amendments to the By-laws of the Fund	Genetic Engineering News:  Jul 18 2008 1:48PM Matching: n
One SNP linked to two diseasesaddiction and cancer: A Double Whammy?: Nicotine addiction and lung cancer susce	Nature:  Jul 18 2008 12:05PM Matching: n
Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity	Earthtimes.org:  Jul 18 2008 12:01PM Matching: n
Merck to fund settlement with former Vioxx painkiller users in August	Macro World Investor:  Jul 18 2008 9:07AM Matching: n
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

N-Acetylgalactosaminyltransferases Patents:
US Patent No.	Title
6168934	Oligosaccharide enzyme substrates and inhibitors: methods and compositions
7078206	UDP-N-acetylglucosamine: galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-R/ (GlcNAc to GalNAc) .beta.1,6N-acetylglucosaminyltransferase, C2GnT3
7094887	UDP-N-acetylglucosamine: galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-R(GlcNAc to GalNAc) .beta.1,6-N-acetylglucosaminyltransferase, C2GnT3
7097994	UDP-N-acetylglucosamine:galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-- R/ (GlcNAc to GaINAc) .beta.1-6 N-acetylglucosaminyltransferase, C2GnT3
7125843	Glycoconjugates including more than one peptide
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for N-Acetylgalactosaminyltransferases scientists - we have details of around 65 individuals working on N-Acetylgalactosaminyltransferases .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.